1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor

The present invention relates to the use of a compound of formula (I): or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product for the prevention and/or the treatment of a disease in which the GLP-1 receptor participates or mediates, such as eating disorder...

Full description

Saved in:
Bibliographic Details
Main Authors ORIO ORTÍZ LAURA, ALONSO SCRIGNOLI MONICA, ROMERO CUEVAS MIGUEL, RODRÍGUEZ DE FONSECA FERNANDO ANTONIO, DECARA DEL OLMO JUAN MANUEL
Format Patent
LanguageEnglish
Published 09.06.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of a compound of formula (I): or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product for the prevention and/or the treatment of a disease in which the GLP-1 receptor participates or mediates, such as eating disorders or diseases, for example, obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism and cardiovascular diseases or metabolic syndrome.
Bibliography:Application Number: US201113981554